Head and Neck Pathology

, Volume 1, Issue 2, pp 104–111 | Cite as

Origin of Endolymphatic Sac Tumor

Original Research
First Online:
Received:
Accepted:

Abstract

Autopsy temporal bone sections showing a one mm papillary glandular neoplasm, confined to the left endolymphatic duct, are described. This is the second literature report confirming the post-mortem site of origin of the “endolymphatic sac tumor”. The patient died after surgery for right vestibular schwannoma, but no features of von Hippel Lindau disease or neurofibromatosis 2 had been displayed clinically or at autopsy. A study of the epithelium of normal human mature endolymphatic ducts and sacs (EDSs) in archival temporal bone sections showed hyperplastic tubular outgrowths, usually situated in the intraosseous portion of the endolymphatic sac, in most cases. Such appearances imply that the epithelium of the EDS has the potential of producing a malignant papillary glandular neoplasm. Papillary ingrowths, some forming collagenous polypoid projections, and cysts were frequent among the epithelial cells. Psammoma bodies were present in the ducts and sacs of older patients. Appearances suggesting erosion of the bony interface of vestibular aqueduct with EDS could be ascribed to the entry and exit of blood vessels into and from the vestibular aqueduct. Care should be taken in the evaluation of surgical or autopsy material from EDSs not to overcall any of these normal features as malignant.

Keywords

Endolymphatic sac/duct tumor Autopsy von Hippel Lindau disease Vestibular schwannoma 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Salt AN, Rask-Andersen H. Responses of the endolymphatic sac to perilymphatic injections and withdrawals: evidence for the presence of a one-way valve. Hear Res 2004;191:90–100.PubMedCrossRefGoogle Scholar
  2. 2.
    Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin. A clinicopathologic study of 20 cases. Cancer 1989;64:2292–302.PubMedCrossRefGoogle Scholar
  3. 3.
    Manski TJ, Heffner DK, Glenn GM, et al. Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel Lindau disease. JAMA 1997;277:1461–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Lonser RR, Kim HJ, Butman JA, et al. Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med 2004;350:2481–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Kim J, Butman J, Brewer C. Tumors of the endolymphatic sac in patients with von Hippel–Lindau disease: implications for their natural history, diagnosis, and treatment. J Neurosurg 2005;102:503–12.PubMedGoogle Scholar
  6. 6.
    Bui HT, Galey FR, Linthicum FH, Jr. Electron microscopy of hyalin bodies in the human intraosseous endolymphatic sac. Am J Otol 1989;10:285–8.Google Scholar
  7. 7.
    Ng M, Linthicum FH. Periductal vessels of the endolymphatic duct. Acta Otolaryngol (Stockh) 1992;112:649–57.Google Scholar
  8. 8.
    Ng M. Postnatal maturation of the human endolymphatic sac. Laryngoscope 2000;110:1452–1456.PubMedCrossRefGoogle Scholar
  9. 9.
    Calzada MJ, Esteban MA, Feijoo-Cuaresma M, et al. Von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms. Cancer Res 2006;66:1553–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Jensen RL, Gillespie D, House P, Layfield L, Shelton C. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. J Neurosurg 2004;100:488–97.PubMedGoogle Scholar
  11. 11.
    Choo DI, Shotland L, Mastroianni M, et al. Endolymphatic sac tumors in von Hippel-Lindau disease. J Neurosurg 2004;100:480–87.PubMedCrossRefGoogle Scholar
  12. 12.
    Hamazaki S, Yoshida M, Yao M, et al. Mutation of von Hippel-Lindau tumor suppressor gene in a sporadic endolymphatic sac tumor. Hum Pathol 2001;32:1272–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Leonard J, Talbot M. Asymptomatic acoustic neurilemmoma. Arch Otolaryngol 1970;91:117–124.PubMedGoogle Scholar
  14. 14.
    Gläsker S, Lonser RR, Tran MG, et al. Effects of VHL deficiency on endolymphatic duct and sac. Cancer Res 2005;65:10847–53.PubMedCrossRefGoogle Scholar

Copyright information

© Humana 2007

Authors and Affiliations

  1. 1.Department of HistopathologyRoyal Free & UCL Medical SchoolLondonUK

Personalised recommendations